Corticosteroid Therapy in Fibrotic Interstitial Lung Disease: a Modified Delphi Survey

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2024 Oct 8

PMID 39377089

Authors

Manuela Funke-Chambour

Philipp Suter

Gisli R Jenkins

Leticia Kawano-Dourado

Christopher J Ryerson

Athol U Wells

Michael Kreuter

Kerri A Johannson

Affiliations

Soon will be listed here.

Abstract

https://bit.ly/3VkgvbS.

References

Pitre T, Kawano-Dourado L, Kachkovski G, Leung D, Leung G, Desai K . Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis. BMJ Open Respir Res. 2023; 10(1). PMC: 10759070. DOI: 10.1136/bmjresp-2023-002008. View

Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux P, Wijsenbeek M . Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends Mol Med. 2023; 29(12):1076-1087. DOI: 10.1016/j.molmed.2023.08.010. View

Cai M, Bonella F, He X, Sixt S, Sarria R, Guzman J . CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Respir Med. 2013; 107(9):1444-52. DOI: 10.1016/j.rmed.2013.06.004. View

Nili M, Singer D, Hanna M . Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype. BMC Pulm Med. 2022; 22(1):153. PMC: 9034591. DOI: 10.1186/s12890-022-01953-9. View

Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells C . Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin. 2019; 35(11):2015-2024. DOI: 10.1080/03007995.2019.1647040. View

Meyer K, Raghu G, Baughman R, Brown K, Costabel U, du Bois R . An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012; 185(9):1004-14. DOI: 10.1164/rccm.201202-0320ST. View

Yamagata A, Arita M, Tachibana H, Tokioka F, Sugimoto C, Sumikawa H . Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res. 2021; 22(1):115. PMC: 8059166. DOI: 10.1186/s12931-021-01726-8. View

Wijsenbeek M, Cottin V . Spectrum of Fibrotic Lung Diseases. N Engl J Med. 2020; 383(10):958-968. DOI: 10.1056/NEJMra2005230. View

Raghu G, Anstrom K, King Jr T, Lasky J, Martinez F . Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012; 366(21):1968-77. PMC: 3422642. DOI: 10.1056/NEJMoa1113354. View

10.

Behr J, Salisbury M, Walsh S, Podolanczuk A, Hariri L, Hunninghake G . The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. Am J Respir Crit Care Med. 2024; 210(4):392-400. DOI: 10.1164/rccm.202401-0048PP. View

11.

De Sadeleer L, Hermans F, De Dycker E, Yserbyt J, Verschakelen J, Verbeken E . Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir J. 2020; 55(4). DOI: 10.1183/13993003.01983-2019. View

12.

De Sadeleer L, Hermans F, De Dycker E, Yserbyt J, Verschakelen J, Verbeken E . Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study. J Clin Med. 2018; 8(1). PMC: 6352061. DOI: 10.3390/jcm8010014. View

13.

Feng D, Zhou Y, Xing Y, Li C, Lv Q, Dong J . Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics. Ther Clin Risk Manag. 2018; 14:1975-1986. PMC: 6188005. DOI: 10.2147/TCRM.S181043. View

14.

Kokkarinen J, Tukiainen H, Terho E . Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung. Am Rev Respir Dis. 1992; 145(1):3-5. DOI: 10.1164/ajrccm/145.1.3. View

15.

Barnett J, Maher T, Quint J, Adamson A, Wu Z, Smith D . Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases. Am J Respir Crit Care Med. 2023; 208(9):975-982. DOI: 10.1164/rccm.202305-0796OC. View